CURRICULUM VITAE
of the author Dr. Zikopoulos
Athanasios
Author’s Academic Background
2001–2004 Doctor
of Business Administration (DBA)
University of South Australia, Adelaide SA,
In parallel to full-time employment
Doctoral Thesis:
Improving corporate performance by better use of
Pharmacoeconomics in
1999–2001 Master
of Business Administration (MBA),
In parallel to full-time employment
Master Thesis:
Leadership Development: Building a bridge between
theoretical concepts and practice through the evaluation and appraisal of
Merck’s leadership development programme
1984-1988
Master of Sciences (Dipl. Natw. ETH)
Mains subjects: Biochemistry / Molecular Biology /
Immunology
Swiss Federal Institute of Technology
(Eidgenössische Technische Hochschule, ETH,
Zurich, Switzerland)
Master Thesis:
Allelic and Isotypic Exclusion of
T-Zell-Receptor-Genes in TCR-Beta-Chain Transgenic Mice
Author’s Professional Career
01.09.2002 - General Manager
Mundipharma
Medical Company
Affiliate
of the Purdue / Mundipharma / NAPP Group of companies
01.08.2001 –
31.07.2002 Senior
Manager Health Care Affairs
Head
Marketing HIV & Platelet Aggregation Mid-Europe Region
Merck
Sharp & Dohme-Chibret AG (MSD)
01.08.2000 –
31.07.2001 Senior
Manager Health Care Affairs (External /
Health Care Affairs)
Merck
Sharp & Dohme-Chibret AG (MSD)
17.02.1997 – 31.07.2000 National Sales Manager (Sales)
Merck
Sharp & Dohme-Chibret AG (MSD)
Therapy
– Areas: Cardiovascular, Asthma, Rheumatology
01.08.1994 -
31.01.1997 Group
Product Manager (
Pharmacia
01.10.1991 –
31.07.1994 Product
Manager (
Pharmacia
01.09.1989 –
30.09.1991 Area
Manager / Product Specialist (Sales)
Pharmacia
Author’s Additional Assignments
§
Lecturer (Privatdozent Praxis) at ZfU – International Business School, Thalwil (ZH),
§
Lecturer at Donau-University Krems –
§
Project leader pharmacoeconomics of the interdisciplinary
communication group INTERPHARMA / VIPS (the two pharmaceutical associations in
Author’s Publications
§
Zikopoulos A.Pharmacoeconomics for the Pharmaceutical Industry in
§
Pircher H, Ohash P,
Miescher G, Lang R, Zikopoulos A,
Bürki K, Mak T W, MacDonald HR, Hengartner H. T cell receptor beta chain
transgenic mice: studies in allelic exclusion and on the TcR+ gamma/delta population. Eur.
J. Immunol. 1990.20: 417-424
© Copyright-VIPAPHARM. All rights reserved